6,694.00
+44.00
+(0.66%)
At close: January 21 at 2:56:02 PM CST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 25 | 25 | 35 | 34 |
Avg. Estimate | 9.34B | 9.54B | 39.37B | 43.39B |
Low Estimate | 9.25B | 9.39B | 38.74B | 42.21B |
High Estimate | 9.44B | 9.69B | 40.03B | 45.24B |
Year Ago Sales | 8.63B | 8.78B | 35.93B | 39.37B |
Sales Growth (year/est) | 8.18% | 8.76% | 9.58% | 10.22% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
V.MX | -- | -- | -- | -- |
S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Upgrades & Downgrades
Maintains | Citigroup: Buy to Buy | 1/14/2025 |
Upgrade | Seaport Global: Neutral to Buy | 1/14/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 1/3/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 12/19/2024 |
Maintains | Morgan Stanley: Overweight to Overweight | 12/18/2024 |
Maintains | Susquehanna: Positive to Positive | 12/11/2024 |